0 789

Cited 0 times in

Phase I trial of neoadjuvant concurrent chemoradiotherapy with S-1 and weekly irinotecan in locally advanced rectal cancer

DC Field Value Language
dc.contributor.author전성하-
dc.contributor.author정현철-
dc.contributor.author정희철-
dc.contributor.author천재희-
dc.contributor.author최혜진-
dc.contributor.author금기창-
dc.contributor.author김남규-
dc.contributor.author노재경-
dc.contributor.author라선영-
dc.contributor.author백승혁-
dc.contributor.author신상준-
dc.contributor.author안중배-
dc.date.accessioned2015-05-19T16:24:59Z-
dc.date.available2015-05-19T16:24:59Z-
dc.date.issued2008-
dc.identifier.issn0167-8140-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/106265-
dc.description.abstractS-1 is a novel, oral fluoropyrimidine and a known radiosensitizer. We conducted a phase I trial to establish a schedule of S-1/irinotecan with standard pelvic radiotherapy as a preoperative treatment of locally advanced rectal cancer. Our findings suggest that this new combination is feasible and well tolerable-
dc.description.statementOfResponsibilityopen-
dc.format.extent361~366-
dc.relation.isPartOfRADIOTHERAPY AND ONCOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAdenocarcinoma/drug therapy*-
dc.subject.MESHAdenocarcinoma/radiotherapy*-
dc.subject.MESHAdenocarcinoma/surgery-
dc.subject.MESHAdult-
dc.subject.MESHAged-
dc.subject.MESHAntineoplastic Agents, Phytogenic/administration & dosage-
dc.subject.MESHAntineoplastic Combined Chemotherapy Protocols/therapeutic use*-
dc.subject.MESHCamptothecin/administration & dosage-
dc.subject.MESHCamptothecin/analogs & derivatives-
dc.subject.MESHCombined Modality Therapy-
dc.subject.MESHDrug Combinations-
dc.subject.MESHFemale-
dc.subject.MESHHumans-
dc.subject.MESHMale-
dc.subject.MESHMaximum Tolerated Dose-
dc.subject.MESHMiddle Aged-
dc.subject.MESHNeoadjuvant Therapy-
dc.subject.MESHOxonic Acid/administration & dosage*-
dc.subject.MESHOxonic Acid/adverse effects-
dc.subject.MESHRadiation-Sensitizing Agents/adverse effects-
dc.subject.MESHRadiation-Sensitizing Agents/therapeutic use*-
dc.subject.MESHRadiotherapy Dosage-
dc.subject.MESHRadiotherapy, High-Energy-
dc.subject.MESHRectal Neoplasms/drug therapy*-
dc.subject.MESHRectal Neoplasms/radiotherapy*-
dc.subject.MESHRectal Neoplasms/surgery-
dc.subject.MESHTegafur/administration & dosage*-
dc.subject.MESHTegafur/adverse effects-
dc.titlePhase I trial of neoadjuvant concurrent chemoradiotherapy with S-1 and weekly irinotecan in locally advanced rectal cancer-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학)-
dc.contributor.googleauthorHye Jin Choi-
dc.contributor.googleauthorNam-Kyu Kim-
dc.contributor.googleauthorKi Chang Keum-
dc.contributor.googleauthorSeong Ha Cheon-
dc.contributor.googleauthorSang Jun Shin-
dc.contributor.googleauthorSeung Hyuk Baik-
dc.contributor.googleauthorJae Hee Choen-
dc.contributor.googleauthorSun Young Rha-
dc.contributor.googleauthorJae Kyung Roh-
dc.contributor.googleauthorHei-Cheul Jeung-
dc.contributor.googleauthorHyun Cheol Chung-
dc.contributor.googleauthorJoong Bae Ahn-
dc.identifier.doi10.1016/j.radonc.2008.04.001-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA03520-
dc.contributor.localIdA03773-
dc.contributor.localIdA04219-
dc.contributor.localIdA00272-
dc.contributor.localIdA00353-
dc.contributor.localIdA01290-
dc.contributor.localIdA01827-
dc.contributor.localIdA02105-
dc.contributor.localIdA02262-
dc.contributor.localIdA03794-
dc.contributor.localIdA01316-
dc.contributor.localIdA04030-
dc.relation.journalcodeJ02597-
dc.identifier.eissn1879-0887-
dc.identifier.pmid18439695-
dc.identifier.urlhttp://www.sciencedirect.com/science/article/pii/S0167814008001953-
dc.subject.keywordS-1-
dc.subject.keywordIrinotecan-
dc.subject.keywordNeoadjuvant-
dc.subject.keywordRectal cancer-
dc.contributor.alternativeNameCheon, Seong Ha-
dc.contributor.alternativeNameChung, Hyun Cheol-
dc.contributor.alternativeNameJeung, Hei Cheul-
dc.contributor.alternativeNameCheon, Jae Hee-
dc.contributor.alternativeNameChoi, Hye Jin-
dc.contributor.alternativeNameKeum, Ki Chang-
dc.contributor.alternativeNameKim, Nam Kyu-
dc.contributor.alternativeNameRoh, Jae Kyung-
dc.contributor.alternativeNameRha, Sun Young-
dc.contributor.alternativeNameBaik, Seung Hyuk-
dc.contributor.alternativeNameShin, Sang Joon-
dc.contributor.alternativeNameAhn, Joong Bae-
dc.contributor.affiliatedAuthorCheon, Seong Ha-
dc.contributor.affiliatedAuthorChung, Hyun Cheol-
dc.contributor.affiliatedAuthorChoi, Hye Jin-
dc.contributor.affiliatedAuthorKeum, Ki Chang-
dc.contributor.affiliatedAuthorKim, Nam Kyu-
dc.contributor.affiliatedAuthorRoh, Jae Kyung-
dc.contributor.affiliatedAuthorBaik, Seung Hyuk-
dc.contributor.affiliatedAuthorShin, Sang Joon-
dc.contributor.affiliatedAuthorAhn, Joong Bae-
dc.contributor.affiliatedAuthorJeung, Hei Cheul-
dc.contributor.affiliatedAuthorRha, Sun Young-
dc.contributor.affiliatedAuthorCheon, Jae Hee-
dc.rights.accessRightsnot free-
dc.citation.volume87-
dc.citation.number3-
dc.citation.startPage361-
dc.citation.endPage366-
dc.identifier.bibliographicCitationRADIOTHERAPY AND ONCOLOGY, Vol.87(3) : 361-366, 2008-
dc.identifier.rimsid56319-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Radiation Oncology (방사선종양학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.